Have drug combinations supplanted stem cell transplantation in myeloma?

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial2010 · 427 citations
2. 2Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma2012 · 1,162 citations
3. 3Early versus delayed autologous transplantation after immunomodulatory agents‐based induction therapy in patients with newly diagnosed multiple myeloma2011 · 121 citations
4. 4Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols2009 · 100 citations
5. 5Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial2010 · 438 citations